Compare MYGN & UHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MYGN | UHT |
|---|---|---|
| Founded | 1991 | 1986 |
| Country | United States | United States |
| Employees | 2700 | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 523.7M | 525.1M |
| IPO Year | 1996 | 1995 |
| Metric | MYGN | UHT |
|---|---|---|
| Price | $5.44 | $37.46 |
| Analyst Decision | Hold | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $5.90 | N/A |
| AVG Volume (30 Days) | ★ 1.7M | 90.4K |
| Earning Date | 11-04-2026 | 10-27-2026 |
| Dividend Yield | N/A | ★ 8.07% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 1.14 |
| Revenue | ★ $771,400,000.00 | $99,190,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $6.18 |
| P/E Ratio | ★ N/A | $32.61 |
| Revenue Growth | ★ 2.33 | 0.18 |
| 52 Week Low | $2.74 | $36.07 |
| 52 Week High | $8.09 | $46.30 |
| Indicator | MYGN | UHT |
|---|---|---|
| Relative Strength Index (RSI) | 46.99 | 41.45 |
| Support Level | $4.19 | $36.30 |
| Resistance Level | $5.52 | $39.45 |
| Average True Range (ATR) | 0.30 | 0.91 |
| MACD | -0.13 | -0.14 |
| Stochastic Oscillator | 0.00 | 20.98 |
Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.
Universal Health Realty Income Trust is a healthcare REIT. The company is engaged in the business of investing in and leasing healthcare and human service facilities through direct ownership or through joint ventures, which aggregate into a single reportable segment. The company actively manages a portfolio of healthcare and human service facilities. The revenue and net income are generated from the operation of the investment portfolio, located throughout the United States.